Taysha Gene Therapies, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 226.6M |
| FY2021 | 225.9M |
| FY2022 | 263.7M |
| FY2023 | 232.2M |
| FY2024 | 250.1M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 226.6M |
| FY2021 | 225.9M |
| FY2022 | 263.7M |
| FY2023 | 232.2M |
| FY2024 | 250.1M |